Advertisement

Prevalence and Economic Burden of Autism Spectrum Disorder in South Korea Using National Health Insurance Data from 2008 to 2015

  • Minha Hong
  • Sang Min Lee
  • Saengryeol Park
  • Seok-Jun Yoon
  • Young-Eun Kim
  • In-Hwan OhEmail author
Original Paper

Abstract

The prevalence of autism spectrum disorder (ASD) is increasing worldwide. We investigated the economic burden of ASD in South Korea using a nationally representative data source. The direct medical and non-medical costs, and indirect costs resulting from ASD were estimated. The total prevalence was 5.04 (per 100,000) in 2008, and 10.97 in 2015. The economic cost of ASD was estimated to be $2,700,596 in 2008 and $9,645,503 in 2015. Of the total economic cost in 2015, 72.3% was from direct costs and 27.7% from indirect costs, and 87.5% related to male patients and 12.5% to female patients. The results suggest that the increase in economic costs was greater than the increase in prevalence.

Keywords

Autism Spectrum Disorder Economic Burden Korea National Health Insurance data 

Notes

Acknowledgments

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (No. HI18C0446).

Author Contributions

All authors listed have contributed sufficiently to the project to be included as authors, and all those who are qualified to be authors are listed in the author byline.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. American Diabetes Association. (2013). Economic costs of diabetes in the U.S. in 2012. Diabetes Care, 36(4), 1033–1046.  https://doi.org/10.2337/dc12-2625.CrossRefPubMedCentralGoogle Scholar
  2. American Psychiatric Association, & DSM-5 Task Force. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). Washington, D.C.: American Psychiatric Association.CrossRefGoogle Scholar
  3. Buescher, A. V., Cidav, Z., Knapp, M., & Mandell, D. S. (2014). Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatrics, 168(8), 721–728.  https://doi.org/10.1001/jamapediatrics.2014.210.CrossRefPubMedGoogle Scholar
  4. Christensen, D. L., Braun, K. V. N., Baio, J., Bilder, D., Charles, J., Constantino, J. N., et al. (2018). Prevalence and Characteristics of autism spectrum disorder among children aged 8 years—Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012. The Morbidity and Mortality Weekly Report Surveillance Summaries, 65(13), 1–23.  https://doi.org/10.15585/mmwr.ss6513a1.CrossRefPubMedGoogle Scholar
  5. Doshi, J. A., Hodgkins, P., Kahle, J., Sikirica, V., Cangelosi, M. J., Setyawan, J., et al. (2012). Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. Journal of the American Academy of Child and Adolescent Psychiatry, 51(10), 990–1002 e1002.  https://doi.org/10.1016/j.jaac.2012.07.008.CrossRefPubMedGoogle Scholar
  6. Ganz, M. L. (2007). The lifetime distribution of the incremental societal costs of autism. Archives of Pediatrics and Adolescent Medicine, 161(4), 343–349.  https://doi.org/10.1001/archpedi.161.4.343.CrossRefPubMedGoogle Scholar
  7. Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., et al. (2014). Heart disease and stroke statistics–2014 update: A report from the American Heart Association. Circulation, 129(3), e28–e292.  https://doi.org/10.1161/01.cir.0000441139.02102.80.CrossRefPubMedGoogle Scholar
  8. Hong, M., Kwack, Y. S., Joung, Y. S., Lee, S. I., Kim, B., Sohn, S. H., et al. (2014). Nationwide rate of attention-deficit hyperactivity disorder diagnosis and pharmacotherapy in Korea in 2008-2011. Asia-Pacific Psychiatry, 6(4), 379–385.  https://doi.org/10.1111/appy.12154.CrossRefPubMedGoogle Scholar
  9. Hong, M., Park, B., Lee, S. M., Bahn, G. H., Kim, M. J., Park, S., … Park, H. (2019). Economic burden and disability-adjusted life years (DALYs) of attention deficit/hyperactivity disorder. Journal of Attention Disorders.  https://doi.org/10.1177/1087054719864632.
  10. Jacob, A., Scott, M., Falkmer, M., & Falkmer, T. (2015). The costs and benefits of employing an adult with autism spectrum disorder: A systematic review. Public Library of Science One, 10(10), e0139896.  https://doi.org/10.1371/journal.pone.0139896.CrossRefPubMedGoogle Scholar
  11. Jarbrink, K., & Knapp, M. (2001). The economic impact of autism in Britain. Autism, 5(1), 7–22.  https://doi.org/10.1177/1362361301005001002.CrossRefPubMedGoogle Scholar
  12. KHPS. Retrieved February 20, 2019 from http://www.khp.re.kr/eng/main.do.
  13. Kogan, M. D., Strickland, B. B., Blumberg, S. J., Singh, G. K., Perrin, J. M., & van Dyck, P. C. (2008). A national profile of the health care experiences and family impact of autism spectrum disorder among children in the United States, 2005-2006. Pediatrics, 122(6), e1149–e1158.  https://doi.org/10.1542/peds.2008-1057.CrossRefPubMedGoogle Scholar
  14. Lee, J., Lee, J. S., Park, S. H., Shin, S. A., & Kim, K. (2017). Cohort profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC). South Korea. International Journal of Epidemiology, 46(2), e15.  https://doi.org/10.1093/ije/dyv319.CrossRefPubMedGoogle Scholar
  15. Leigh, J. P., & Du, J. (2015). Brief Report: Forecasting the Economic Burden of Autism in 2015 and 2025 in the United States. Journal of Autism and Developmental Disorders, 45(12), 4135–4139.  https://doi.org/10.1007/s10803-015-2521-7.CrossRefPubMedGoogle Scholar
  16. Leslie, D. L., & Martin, A. (2007). Health care expenditures associated with autism spectrum disorders. Archives of Pediatrics and Adolescent Medicine, 161(4), 350–355.  https://doi.org/10.1001/archpedi.161.4.350.CrossRefPubMedGoogle Scholar
  17. Lyall, K., Croen, L., Daniels, J., Fallin, M. D., Ladd-Acosta, C., Lee, B. K., et al. (2017). The changing epidemiology of autism spectrum disorders. Annual Review of Public Health, 38, 81–102.  https://doi.org/10.1146/annurev-publhealth-031816-044318.CrossRefPubMedGoogle Scholar
  18. Rogge, N., & Janssen, J. (2019). The economic costs of autism spectrum disorder: A literature review. Journal of Autism and Development Disorders, 49(7), 2873–2900.  https://doi.org/10.1007/s10803-019-04014-z.CrossRefGoogle Scholar
  19. Xiong, N., Yang, L., Yu, Y., Hou, J., Li, J., Li, Y., et al. (2011). Investigation of raising burden of children with autism, physical disability and mental disability in China. Research in Developmental Disabilities, 32(1), 306–311.  https://doi.org/10.1016/j.ridd.2010.10.003.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Psychiatry, Myongji HospitalHanyang University College of MedicineGoyangSouth Korea
  2. 2.Department of PsychiatryKyung Hee University School of MedicineSeoulSouth Korea
  3. 3.Department of Preventive MedicineKyung Hee University School of MedicineSeoulSouth Korea
  4. 4.Department of Preventive MedicineKorea University College of MedicineSeoulSouth Korea

Personalised recommendations